Immunoassays

The 25-OH Quantitative Rapid Vitamin D Test is a one-step in vitro immunochromatographic assay intended for the quantitative determination of total 25-hydroxy Vitamin D (25-OH Vitamin D) in human finger-prick capillary whole blood. The assay is intended for near-patient screening of Vitamin D status and Vitamin D deficiency. Results provide a preliminary diagnostic measurement and should be interpreted together with clinical information; confirmatory testing using LC-MS/MS or another quantitative immunoassay may be performed when clinically appropriate.

The Avidity Epstein-Barr Virus (VCA) IgG ELISA is intended to indicate the Epstein-Barr virus viral capsid antigen (VCA)-specific IgG avidity in human serum or plasma (citrate, heparin) to differentiate between acute and past infection.

The Avidity Measles Virus IgG ELISA is intended to indicate the Measles-specific IgG avidity in human serum or plasma (citrate, heparin) to differentiate between acute and past infection.

The Ascaris lumbricoides IgG ELISA is intended for the qualitative determination of IgG class antibodies against Ascaris lumbricoides in human serum or plasma (citrate, heparin).

The Aspergillus fumigatus IgG ELISA is intended for the qualitative determination of IgG class antibodies against Aspergillus fumigatus in human serum or plasma (citrate, heparin).

The Aspergillus fumigatus IgM ELISA is intended for the qualitative determination of IgM class antibodies against Aspergillus fumigatus in human serum or plasma (citrate, heparin).

The Bartonella ELISA is intended for the qualitative determination of specific antibodies against Bartonella in human serum or plasma (heparin).

The Chagas (Trypanosoma cruzi) IgG ELISA is intended for the qualitative determination of IgG class antibodies against Trypanosoma cruzi in human serum or plasma (citrate, heparin).

The Dengue Virus IgM µ-capture ELISA is intended for the qualitative determination of IgM class antibodies against Dengue virus in human serum or plasma (citrate, heparin).

The Epstein-Barr Virus (EA-D) IgG ELISA is intended for the qualitative determination of IgG class antibodies against EpsteinBarr virus early antigen (EA-D) in human serum or plasma (citrate, heparin). The ELISA is intended for use as an aid in identifying individuals with an adaptive immune response to Epstein-Barr virus, indicating recent or prior infection